MicroRNAs as biomarkers in solid organ transplantation

Valeria Mas, C. I. Dumur, M. J. Scian, R. C. Gehrau, Daniel Maluf

Research output: Contribution to journalReview article

57 Citations (Scopus)

Abstract

Important progress has been made in improving short-term outcomes in solid organ transplantation. However, long-term outcomes have not improved during the last decades. There is a critical need for biomarkers of donor quality, early diagnosis of graft injury and treatment response. MicroRNAs (miRNAs) are a class of small single-stranded noncoding RNAs that function through translational repression of specific target mRNAs. MiRNA expression has been associated with different diseases and physiological conditions. Moreover, miRNAs have been detected in different biological fluids and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA detection, their disease specificity and the availability of accurate techniques for detecting and monitoring these molecules has encouraged a pursuit of miRNA biomarker research and the evaluation of specific applications in the transplant field. miRNA expression might develop as excellent biomarkers of allograft injury and function. In this minireview, we summarize the main accomplishments of recently published reports focused on the identification of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction emphasizing their mechanistic and clinical potential applications and describing their methodological limitations. The authors summarize recent reports detailing the identification, mechanism, clinical application and limitations of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction.

Original languageEnglish (US)
Pages (from-to)11-19
Number of pages9
JournalAmerican Journal of Transplantation
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Organ Transplantation
MicroRNAs
Biomarkers
Transplantation Tolerance
Reperfusion Injury
Transplants
Untranslated RNA
Wounds and Injuries
Allografts
Early Diagnosis
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

MicroRNAs as biomarkers in solid organ transplantation. / Mas, Valeria; Dumur, C. I.; Scian, M. J.; Gehrau, R. C.; Maluf, Daniel.

In: American Journal of Transplantation, Vol. 13, No. 1, 01.01.2013, p. 11-19.

Research output: Contribution to journalReview article

Mas, Valeria ; Dumur, C. I. ; Scian, M. J. ; Gehrau, R. C. ; Maluf, Daniel. / MicroRNAs as biomarkers in solid organ transplantation. In: American Journal of Transplantation. 2013 ; Vol. 13, No. 1. pp. 11-19.
@article{bc31a05a1ffe4c4aadbf626f071b20b3,
title = "MicroRNAs as biomarkers in solid organ transplantation",
abstract = "Important progress has been made in improving short-term outcomes in solid organ transplantation. However, long-term outcomes have not improved during the last decades. There is a critical need for biomarkers of donor quality, early diagnosis of graft injury and treatment response. MicroRNAs (miRNAs) are a class of small single-stranded noncoding RNAs that function through translational repression of specific target mRNAs. MiRNA expression has been associated with different diseases and physiological conditions. Moreover, miRNAs have been detected in different biological fluids and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA detection, their disease specificity and the availability of accurate techniques for detecting and monitoring these molecules has encouraged a pursuit of miRNA biomarker research and the evaluation of specific applications in the transplant field. miRNA expression might develop as excellent biomarkers of allograft injury and function. In this minireview, we summarize the main accomplishments of recently published reports focused on the identification of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction emphasizing their mechanistic and clinical potential applications and describing their methodological limitations. The authors summarize recent reports detailing the identification, mechanism, clinical application and limitations of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction.",
author = "Valeria Mas and Dumur, {C. I.} and Scian, {M. J.} and Gehrau, {R. C.} and Daniel Maluf",
year = "2013",
month = "1",
day = "1",
doi = "10.1111/j.1600-6143.2012.04313.x",
language = "English (US)",
volume = "13",
pages = "11--19",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - MicroRNAs as biomarkers in solid organ transplantation

AU - Mas, Valeria

AU - Dumur, C. I.

AU - Scian, M. J.

AU - Gehrau, R. C.

AU - Maluf, Daniel

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Important progress has been made in improving short-term outcomes in solid organ transplantation. However, long-term outcomes have not improved during the last decades. There is a critical need for biomarkers of donor quality, early diagnosis of graft injury and treatment response. MicroRNAs (miRNAs) are a class of small single-stranded noncoding RNAs that function through translational repression of specific target mRNAs. MiRNA expression has been associated with different diseases and physiological conditions. Moreover, miRNAs have been detected in different biological fluids and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA detection, their disease specificity and the availability of accurate techniques for detecting and monitoring these molecules has encouraged a pursuit of miRNA biomarker research and the evaluation of specific applications in the transplant field. miRNA expression might develop as excellent biomarkers of allograft injury and function. In this minireview, we summarize the main accomplishments of recently published reports focused on the identification of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction emphasizing their mechanistic and clinical potential applications and describing their methodological limitations. The authors summarize recent reports detailing the identification, mechanism, clinical application and limitations of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction.

AB - Important progress has been made in improving short-term outcomes in solid organ transplantation. However, long-term outcomes have not improved during the last decades. There is a critical need for biomarkers of donor quality, early diagnosis of graft injury and treatment response. MicroRNAs (miRNAs) are a class of small single-stranded noncoding RNAs that function through translational repression of specific target mRNAs. MiRNA expression has been associated with different diseases and physiological conditions. Moreover, miRNAs have been detected in different biological fluids and these circulating miRNAs can distinguish diseased individuals from healthy controls. The noninvasive nature of circulating miRNA detection, their disease specificity and the availability of accurate techniques for detecting and monitoring these molecules has encouraged a pursuit of miRNA biomarker research and the evaluation of specific applications in the transplant field. miRNA expression might develop as excellent biomarkers of allograft injury and function. In this minireview, we summarize the main accomplishments of recently published reports focused on the identification of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction emphasizing their mechanistic and clinical potential applications and describing their methodological limitations. The authors summarize recent reports detailing the identification, mechanism, clinical application and limitations of miRNAs as biomarkers in organ quality, ischemia-reperfusion injury, acute rejection, tolerance and chronic allograft dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=84871722014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871722014&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2012.04313.x

DO - 10.1111/j.1600-6143.2012.04313.x

M3 - Review article

VL - 13

SP - 11

EP - 19

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 1

ER -